Literature DB >> 28485572

Citrullination/Methylation Crosstalk on Histone H3 Regulates ER-Target Gene Transcription.

Kathleen W Clancy1,2, Anna-Maria Russell1, Venkataraman Subramanian2, Hannah Nguyen1, Yuewei Qian1, Robert M Campbell1, Paul R Thompson2,3.   

Abstract

Posttranslational modifications of histone tails are a key contributor to epigenetic regulation. Histone H3 Arg26 and Lys27 are both modified by multiple enzymes, and their modifications have profound effects on gene expression. Citrullination of H3R26 by PAD2 and methylation of H3K27 by PRC2 have opposing downstream impacts on gene regulation; H3R26 citrullination activates gene expression, and H3K27 methylation represses gene expression. Both of these modifications are drivers of a variety of cancers, and their writer enzymes, PAD2 and EZH2, are the targets of drug therapies. After biochemical and cell-based analysis of these modifications, a negative crosstalk interaction is observed. Methylation of H3K27 slows citrullination of H3R26 30-fold, whereas citrullination of H3R26 slows methylation 30,000-fold. Examination of the mechanism of this crosstalk interaction uncovered a change in structure of the histone tail upon citrullination which prevents methylation by the PRC2 complex. This mechanism of crosstalk is reiterated in cell lines using knockdowns and inhibitors of both enzymes. Based our data, we propose a model in which, after H3 Cit26 formation, H3K27 demethylases are recruited to the chromatin to activate transcription. In total, our studies support the existence of crosstalk between citrullination of H3R26 and methylation of H3K27.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28485572      PMCID: PMC5536191          DOI: 10.1021/acschembio.7b00241

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  67 in total

Review 1.  DNA methylation and gene silencing in cancer.

Authors:  Stephen B Baylin
Journal:  Nat Clin Pract Oncol       Date:  2005-12

2.  EZH2 mutational status predicts poor survival in myelofibrosis.

Authors:  Paola Guglielmelli; Flavia Biamonte; Joannah Score; Claire Hidalgo-Curtis; Francisco Cervantes; Margherita Maffioli; Tiziana Fanelli; Thomas Ernst; Nils Winkelman; Amy V Jones; Katerina Zoi; Andreas Reiter; Andrew Duncombe; Laura Villani; Alberto Bosi; Giovanni Barosi; Nicholas C P Cross; Alessandro M Vannucchi
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

3.  The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states.

Authors:  Tim J Wigle; Sarah K Knutson; Lei Jin; Kevin W Kuntz; Roy M Pollock; Victoria M Richon; Robert A Copeland; Margaret Porter Scott
Journal:  FEBS Lett       Date:  2011-08-17       Impact factor: 4.124

4.  Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation.

Authors:  Jung-Mao Hsu; Chun-Te Chen; Chao-Kai Chou; Hsu-Ping Kuo; Long-Yuan Li; Chun-Yi Lin; Hong-Jen Lee; Ying-Nai Wang; Mo Liu; Hsin-Wei Liao; Bin Shi; Chien-Chen Lai; Mark T Bedford; Chang-Hai Tsai; Mien-Chie Hung
Journal:  Nat Cell Biol       Date:  2011-01-23       Impact factor: 28.824

5.  Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity.

Authors:  Leen De Rycke; Anthony P Nicholas; Tineke Cantaert; Elli Kruithof; Joshua D Echols; Bart Vandekerckhove; Eric M Veys; Filip De Keyser; Dominique Baeten
Journal:  Arthritis Rheum       Date:  2005-08

6.  Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination.

Authors:  Kevin L Bicker; Venkataraman Subramanian; Alexander A Chumanevich; Lorne J Hofseth; Paul R Thompson
Journal:  J Am Chem Soc       Date:  2012-10-03       Impact factor: 15.419

7.  An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.

Authors:  Kyle D Konze; Anqi Ma; Fengling Li; Dalia Barsyte-Lovejoy; Trevor Parton; Christopher J Macnevin; Feng Liu; Cen Gao; Xi-Ping Huang; Ekaterina Kuznetsova; Marie Rougie; Alice Jiang; Samantha G Pattenden; Jacqueline L Norris; Lindsey I James; Bryan L Roth; Peter J Brown; Stephen V Frye; Cheryl H Arrowsmith; Klaus M Hahn; Gang Greg Wang; Masoud Vedadi; Jian Jin
Journal:  ACS Chem Biol       Date:  2013-04-24       Impact factor: 5.100

8.  Human PAD4 regulates histone arginine methylation levels via demethylimination.

Authors:  Yanming Wang; Joanna Wysocka; Joyce Sayegh; Young-Ho Lee; Julie R Perlin; Lauriebeth Leonelli; Lakshmi S Sonbuchner; Charles H McDonald; Richard G Cook; Yali Dou; Robert G Roeder; Steven Clarke; Michael R Stallcup; C David Allis; Scott A Coonrod
Journal:  Science       Date:  2004-09-02       Impact factor: 47.728

9.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.

Authors:  Laurens Kruidenier; Chun-wa Chung; Zhongjun Cheng; John Liddle; KaHing Che; Gerard Joberty; Marcus Bantscheff; Chas Bountra; Angela Bridges; Hawa Diallo; Dirk Eberhard; Sue Hutchinson; Emma Jones; Roy Katso; Melanie Leveridge; Palwinder K Mander; Julie Mosley; Cesar Ramirez-Molina; Paul Rowland; Christopher J Schofield; Robert J Sheppard; Julia E Smith; Catherine Swales; Robert Tanner; Pamela Thomas; Anthony Tumber; Gerard Drewes; Udo Oppermann; Dinshaw J Patel; Kevin Lee; David M Wilson
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

10.  Citrullination regulates pluripotency and histone H1 binding to chromatin.

Authors:  Maria A Christophorou; Gonçalo Castelo-Branco; Richard P Halley-Stott; Clara Slade Oliveira; Remco Loos; Aliaksandra Radzisheuskaya; Kerri A Mowen; Paul Bertone; José C R Silva; Magdalena Zernicka-Goetz; Michael L Nielsen; John B Gurdon; Tony Kouzarides
Journal:  Nature       Date:  2014-01-26       Impact factor: 49.962

View more
  15 in total

1.  Photochemical Control of Protein Arginine Deiminase (PAD) Activity.

Authors:  Santanu Mondal; Sangram S Parelkar; Mitesh Nagar; Paul R Thompson
Journal:  ACS Chem Biol       Date:  2018-03-16       Impact factor: 5.100

2.  Calcium Regulates the Nuclear Localization of Protein Arginine Deiminase 2.

Authors:  Li Zheng; Mitesh Nagar; Aaron J Maurais; Daniel J Slade; Sangram S Parelkar; Scott A Coonrod; Eranthie Weerapana; Paul R Thompson
Journal:  Biochemistry       Date:  2019-06-27       Impact factor: 3.162

3.  12-Plex DiLeu Isobaric Labeling Enabled High-Throughput Investigation of Citrullination Alterations in the DNA Damage Response.

Authors:  Zihui Li; Bin Wang; Qinying Yu; Yatao Shi; Lingjun Li
Journal:  Anal Chem       Date:  2022-02-07       Impact factor: 8.008

4.  Histone modification dynamics as revealed by multicolor immunofluorescence-based single-cell analysis.

Authors:  Yoko Hayashi-Takanaka; Yuto Kina; Fumiaki Nakamura; Leontine E Becking; Yoichi Nakao; Takahiro Nagase; Naohito Nozaki; Hiroshi Kimura
Journal:  J Cell Sci       Date:  2020-07-21       Impact factor: 5.285

5.  Thioredoxin Modulates Protein Arginine Deiminase 4 (PAD4)-Catalyzed Citrullination.

Authors:  Mitesh Nagar; Ronak Tilvawala; Paul R Thompson
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

Review 6.  Histone citrullination: a new target for tumors.

Authors:  Dongwei Zhu; Yue Zhang; Shengjun Wang
Journal:  Mol Cancer       Date:  2021-06-11       Impact factor: 27.401

7.  Widespread enhancer activation via ERα mediates estrogen response in vivo during uterine development.

Authors:  Wendy N Jefferson; H Karimi Kinyamu; Tianyuan Wang; Adam X Miranda; Elizabeth Padilla-Banks; Alisa A Suen; Carmen J Williams
Journal:  Nucleic Acids Res       Date:  2018-06-20       Impact factor: 16.971

8.  A Novel Citrullinated Modification of Histone 3 and Its Regulatory Mechanisms Related to IPO-38 Antibody-Labeled Protein.

Authors:  Shuzheng Song; Zhen Xiang; Jun Li; Jun Ji; Ranlin Yan; Zhenggang Zhu; Yingyan Yu
Journal:  Front Oncol       Date:  2019-04-18       Impact factor: 6.244

9.  Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis.

Authors:  Yuzi Tian; Shibin Qu; Hasan B Alam; Aaron M Williams; Zhenyu Wu; Qiufang Deng; Baihong Pan; Jing Zhou; Baoling Liu; Xiuzhen Duan; Jianjie Ma; Santanu Mondal; Paul R Thompson; Kathleen A Stringer; Theodore J Standiford; Yongqing Li
Journal:  JCI Insight       Date:  2020-10-15

10.  PAD2-mediated citrullination of Fibulin-5 promotes elastogenesis.

Authors:  Bo Sun; Beverly Tomita; Ari Salinger; Ronak R Tilvawala; Ling Li; Hana Hakami; Tao Liu; Konstantin Tsoyi; Ivan O Rosas; Dieter P Reinhardt; Paul R Thompson; I-Cheng Ho
Journal:  Matrix Biol       Date:  2021-07-15       Impact factor: 10.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.